Cerebral Vasospasm Clinical Trials

40 clinical trials for Cerebral Vasospasm across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Nitric Oxide Consumption as a Predictor of Vasospasm in Subarachnoid Hemorrhage — RECRUITING
• Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts — RECRUITING
• Cervical Sympathetic Block in Patients With Cerebral Vasospasm — RECRUITING · NA
• Incidence, Characteristics and Evolution of Cerebral Vasospasm With Clinical Impact in Moderate to Severe Traumatic Brain Injury Complicated by Subarachnoid Hemorrhage at Martinique University Hospital — RECRUITING · NA
• Noninvasive CA Monitoring Validation and Autonomic Modulation in Aneurysmal Subarachnoid Hemorrhage — NOT_YET_RECRUITING · NA
• Cervical Spinal Cord Stimulation in Patients With Cerebral Vasospasm After Subarachnoid Haemorrhage: VasoStim Study — TERMINATED · NA
• Predictive Model for the Occurrence of Cerebral Vasospasm Complicating Subarachnoid Haemorrhage by Combined Analysis of the Kinetics of a Panel of Biomarkers. — COMPLETED · NA
• The Intra-arterial Vasospasm Trial — TERMINATED · PHASE4
• Acetaminophen in aSAH to Inhibit Lipid Peroxidation and Cerebral Vasospasm — TERMINATED · PHASE3
• CT Perfusion Imaging to Predict Vasospasm in Subarachnoid Hemorrhage — ACTIVE_NOT_RECRUITING · NA
• Identification of Novel Molecular Markers for Vasospasm — COMPLETED
• Stellate Ganglion Block and Cerebral Vasospasm — OTHER · NA
• "The Effect of Stellate Ganglion Block in Severe Brain Injury" — COMPLETED · NA
• Safety Study of Sildenafil in Treatment of Cerebral Aneurysm Vasospasm — WITHDRAWN · PHASE2
• Vesalio NeVa VS for Symptomatic Cerebral Vasospasm Following aSAH (The VITAL Study) — COMPLETED · NA
• Magnesium Treating Subarachnoid Hemorrhage Vasospasm — OTHER · PHASE2
• Non-Significant Risk Study Comparing the Nautilus NeuroWaveTM to Transcranial Doppler as an Aid to Diagnosing Vasospasm — COMPLETED
• Safety of Intravenous Milrinone for the Treatment of Subarachnoid Hemorrhage-induced Vasospasm — COMPLETED
• Role of CT Perfusion in Predicting Poor Outcome After Subarachnoid Hemorrhage — COMPLETED
• Sildenafil for DCI — OTHER · PHASE1
• Stellate Ganglion Block in Preventing Cerebral Vasospasm Secondary to Subarachnoid Hemorrhage — OTHER · NA
• Milrinone in Addition to Hyperdynamic Therapy in the Treatment of Vasospasm Following Aneurysmal Subarachnoid Hemorrhage — TERMINATED · PHASE2
• Acupuncture for Cerebral Vasospasm After Subarachnoid Hemorrhage — COMPLETED · NA
• Cervical Spinal Cord Stimulation in Cerebral Vasospasm — WITHDRAWN · NA
• Bilateral Bispectral Index (BIS) Study — COMPLETED
• Remote Ischemic Preconditioning in Subarachnoid Hemorrhage — COMPLETED · PHASE1
• Stellate Ganglion Block Using Ultrasound Guidance For Treatment Of Post Clipping Cerebral Vasospasm — COMPLETED · PHASE1
• Safety and Feasibility of Hypertonic Saline Solution After Aneurysmal Subarachnoid Hemorrhage: — OTHER · PHASE1
• Continuous Neurophysiological Monitoring Detection of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage Subjects — TERMINATED · PHASE1
• Use of Simvastatin for the Prevention of Vasospasm in Aneurysmal Subarachnoid Hemorrhage — TERMINATED · NA
• Effect of Intraventricular tPA Following Aneurysmal Subarachnoid Hemorrhage — WITHDRAWN · PHASE1
• Use of Brain Oxygen Tension Level and Cleaved-tau Protein to Detect Vasospasm After SAH — TERMINATED
• Sildenafil for Prevention of Cerebral Vasospasm — WITHDRAWN · PHASE2
• Safety Study of Dantrolene in Subarachnoid Hemorrhage — COMPLETED · PHASE1
• Safety Study of Carotid Body Neurostimulation to Treat Cerebral Vasospasm — OTHER · NA
• Computed Tomographic (CT) Perfusion and CT Angiography as Screening Tools for Vasospasm Following Subarachnoid Hemorrhage — COMPLETED
• Role of Proteomics and Metallomics in Cerebral Vasospasm Following Subarachnoid Hemorrhage — COMPLETED
• Quality of Life in Elderly After Aneurysmal Subarachnoid Hemorrhage (SAH) — COMPLETED
• Safety Study of Nicardipine to Treat Cerebral Vasospasm — TERMINATED · PHASE2
• Eicosapentaenoic Acid Cerebral Vasospasm Therapy Study — COMPLETED · PHASE4

Refine this search